Save 10% off on your first order with coupon code: PANDA10

Pandameds.Com Editorial Team

The Pandameds.Com Editorial Team is dedicated to delivering accurate, transparent and trustworthy health information to help U.S. customers access safe, affordable weight loss medications from Canada. Our team of experienced medical writers, pharmacists and industry professionals ensures every article and product page is thoroughly fact checked, clearly written & updated to reflect the latest clinical guidance.

Each piece of content undergoes a stringent editorial process referencing trusted medical sources such as FDA, Health Canada, PubMed and Mayo Clinic. While we do not provide individual medical advice, our mission is to empower readers with reliable knowledge about medications like Ozempic, Saxenda, Mounjaro, Zepbound, Wegovy and Rybelsus, focused exclusively on their role in medical weight management.

Pandameds.Com helps our readers make informed decisions about their health maintaining a transparent editorial policy and working with certified reviewers

Recent Blog Post

31Jan, 2026

Wegovy Side Effects 2026: GI Issues 44%, Hair Loss 3%, Eye Problems 1.6%

January 31, 2026|

Wegovy causes GI side effects in 44% of users, hair loss in 3%, and eye issues in 1.6% of diabetic patients with the highest rates occurring at the 2.4mg maintenance dose.  The most frequently reported reactions are gastrointestinal: nausea affects 44% of adults (compared to 16% on placebo), while diarrhea occurs in 30% of users. [...]

30Jan, 2026

Victoza vs Ozempic: Complete Comparison Guide 2026

January 30, 2026|

When comparing Victoza (liraglutide) and Ozempic (semaglutide) for diabetes treatment, both injectable medications belong to the same class of drugs known as glucagon-like peptide 1 (GLP 1) receptor agonists. Manufactured by Novo Nordisk, these prescription drugs help treat type 2 diabetes and support weight management and have proven effective in clinical trials for lowering blood [...]

30Jan, 2026

Ozempic Kidney Safety 2026: Pain, Damage & CKD Protection

January 30, 2026|

Ozempic protect the kidneys. This is now officially confirmed by the FDA. In January 2025, Ozempic (semaglutide) was approved as the first and only GLP 1 receptor agonist indicated to reduce the risk of worsening kidney disease, kidney failure and cardiovascular death in adults with type 2 diabetes and chronic kidney disease (CKD). The landmark [...]

30Jan, 2026

Ozempic Butt 2026: What It Is And How It Can Be Avoided & Fixed

January 30, 2026|

Ozempic butt refers to the deflated, sagging or flat appearance of the buttocks that occurs after significant weight loss from GLP-1 receptor agonist medications like semaglutide (Ozempic, Wegovy) or tirzepatide (Mounjaro, Zepbound). This phenomenon happens when rapid fat loss outpaces your skin’s ability to retract, combined with muscle loss that removes the underlying structure supporting [...]

30Jan, 2026

Does Ozempic Cause Cancer? – Thyroid Risk & 2026 Safety Data

January 30, 2026|

Current evidence does not show that Ozempic (semaglutide) causes an increased risk of cancer in humans. The concern about Ozempic and cancer stems primarily from animal studies where rodents developed thyroid C cell tumors when given semaglutide. However, no cases of thyroid cancer were reported in clinical trials of Ozempic and the incidence of thyroid [...]

30Jan, 2026

Trulicity vs Ozempic: Complete Comparison for Diabetes & Weight Loss 2026

January 30, 2026|

Ozempic works better than Trulicity for both weight loss and blood sugar control. In clinical trials, Ozempic users lost 10 to 14 pounds on average while Trulicity users lost only 5 to 7 pounds. Ozempic also reduced A1C levels more effectively. Your doctor will guide your final choice. When it comes to Trulicity [...]

29Jan, 2026

Does Ozempic Make You Tired? – Complete Guide to Ozempic Fatigue

January 29, 2026|

Yes, Ozempic can make you tired, but fatigue is not among the most common side effects. Clinical trials indicate that fatigue affects approximately 0.4% of participants taking Ozempic for diabetes management, while up to 11% may experience tiredness when using higher doses for weight loss. Ozempic (semaglutide) affects how your body releases insulin, slows gastric [...]

29Jan, 2026

Ozempic Vision Loss, Blurred Vision & Eye Problems

January 29, 2026|

Ozempic (semaglutide) has transformed weight management, but emerging research has revealed concerning links between this popular GLP-1 receptor agonist and serious eye complications. The most alarming finding involves non-arteritic anterior ischemic optic neuropathy (NAION). A study showed that diabetic patients taking semaglutide were over four times more likely to be diagnosed with NAION than those [...]

29Jan, 2026

Ozempic Diarrhea: Causes, Duration and Relief

January 29, 2026|

Ozempic diarrhea is one of the most common side effects experienced by patients taking this GLP-1 receptor agonist medication for blood glucose control and weight management. Diarrhea affects approximately 8-30% of Ozempic users, with the highest incidence occurring during the first four weeks of treatment or after dose increases.  While this gastrointestinal adverse event can [...]

Go to Top
X